Market sizing and growth strategy for medical device company
Respiratory remote patient monitoring data startup with >$50M in equity financing needed help identifying growth opportunities in pulmonary disease treatment
• Sized total addressable market (TAM) of new and incumbent treatment providers and hub services providers • Identified attractive segments for market entry by analyzing marketed products for COPD medical interventions (e.g., price point and administration complexity for anticholinergic inhalers, beta-agonist inhalers, combination therapy, etc.) • Analyzed case studies of analogous real-world data usage in prospective studies in respiratory patients to improve medication adherence Impact: • >$10B Total addressable market identified • >60 Products analyzed